NCT01590472 Do Your Genes Put You at a Higher Risk of Developing Mesothelioma Status COMPLETED Phase N/A
NCT01583686 CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01569919 A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma Status UNKNOWN Phase PHASE2
NCT01521325 A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers Status COMPLETED Phase PHASE1
NCT01445392 SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma Status TERMINATED Phase PHASE1
NCT01401907 Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies Status COMPLETED Phase NA
NCT01362790 SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma Status COMPLETED Phase PHASE1/PHASE2
NCT01356251 Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma Status COMPLETED Phase NA
NCT01281800 Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma Status UNKNOWN Phase PHASE2
NCT01204203 Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) Status COMPLETED Phase PHASE2
NCT01188486 Pulmonary Interstitial Lymphography in Early Stage Lung Cancer Status TERMINATED Phase NA
NCT01134146 Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT) Status COMPLETED Phase PHASE1
NCT00996385 Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma Status UNKNOWN Phase PHASE2
NCT00895648 Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma Status TERMINATED Phase PHASE2